Tracer may provide alternative for imaging epilepsy

07/18/2013 | MolecularImaging.net

A study reported in the Journal of Nuclear Medicine found that F-18 flumazenil PET may be used in place of F-18 FDG PET for localizing the epileptogenic zone in cases of the most common adult form of drug-resistant epilepsy. "F-18 FMZ may provide a different and complementary measure of the epileptogenic substrate to [previous] clinical assessments. Importantly, the F-18 FMZ [binding potential] images could be constructed using a method that did not require arterial blood sampling, making it suitable for routine clinical practice," according to the authors.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA